Evidence map›Paper›PMID 36958067›Full record

ArticleInternational journal for parasitology. Drugs and drug resistance2023

Emergence of Ancylostoma caninum parasites with the benzimidazole resistance F167Y polymorphism in the US dog population.

Christian M Leutenegger, Cecilia E Lozoya, Jeffrey Tereski, Christian Savard, Jennifer Ogeer, Rene Lallier

Open access · goldAbstract read
In one paragraph

Article in International journal for parasitology. Drugs and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Prevalence and distribution ofOne health (Amsterdam, Netherlands) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Christian M LeuteneggerAntech Diagnostics, Innovation Molecular Diagnostics R&D, Fountain Valley, CA, USA. Electronic address: christian.leutenegger@antechmail.com.
Cecilia E LozoyaAntech Diagnostics, Innovation Molecular Diagnostics R&D, Fountain Valley, CA, USA. Electronic address: cecilia.lozoya@antechmail.com.
Jeffrey TereskiAntech Diagnostics, Innovation Molecular Diagnostics R&D, Fountain Valley, CA, USA. Electronic address: jeffrey.tereski@antechmail.com.
Christian SavardBioVet Inc, Saint-Hyacinthe, Québec, Canada. Electronic address: christian.savard@biovet-inc.com.
Jennifer OgeerAntech Diagnostics, Innovation Molecular Diagnostics R&D, Fountain Valley, CA, USA. Electronic address: jennifer.ogeer@antechmail.com.
Rene LallierBioVet Inc, Saint-Hyacinthe, Québec, Canada. Electronic address: rene.lallier@biovet-inc.com.
CS Diagnostics · DECegep de Saint Hyacinthe · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnthelmintic resistance to benzimidazole has been detected in the canine hookworm, Ancylostoma caninum. Benzimidazole resistance is believed to have developed originally in greyhounds, but has also been detected in non-greyhound pet dogs. The aim of this study was to validate a probe-based allele-specific real-time PCR tests for the F167Y polymorphism on the β-tubulin isotype-1 gene and to determine the geographic distribution.

methodsAllele-specific real-time PCR tests were established and validated to detect the codon 167 polymorphism in the Ancylostoma caninum β-tubulin isotype-1gene. Additionally, real-time PCR tests were validated for Ancylostoma spp. and Uncinaria stenocephala. Two nucleic acid extraction protocols were validated including mechanical disruption of parasite structures in stool. The frequency of the F167Y single nucleotide polymorphism (SNP) was determined in hookworm confirmed stool samples. Samples with the resistant 167Y genotype were confirmed by β-tubulin gene sequencing and allele frequencies were determined.

resultsThe Ancylostoma spp. and A. caninum F167Y allele-specific real-time PCR tests were highly sensitive and specific when tested against synthetic DNA, spiked samples, and characterized parasites. Using an optimized total nucleic acid extraction protocol, 54 of 511 (10.6%) were found to contain the benzimidazole resistance allele. All 55 samples containing hookworms with the resistance mutation were confirmed by β-tubulin gene sequencing. The majority of resistant hookworms (44 resistant, 183 tested; 24.4%) originated from Florida, five from California (103 tested, 4.9%), three from Idaho (40 tested, 7.5%), two from Nevada (22 tested, 9.1%), and one sample from Hawaii (13 tested, 7.7%). Resistant genotypes were found in 14 different dog breeds including eight in Greyhounds. Allele-frequency determination revealed resistance allele frequencies between 1 and 100% with 58% above 50%.

conclusionsThis data strongly supports recent findings of benzimidazole resistant canine hookworms present throughout the general US pet dog population.

Indexed as

AnthelminticsHookworm InfectionsParasitesAncylostomaAncylostomatoideaAnimalsBenzimidazolesDogsDrug ResistancePolymorphism, Single NucleotideReal-Time Polymerase Chain ReactionTubulinAnthelminticsBenzimidazolesTubulinAncylostoma caninumAnthelmintic resistanceF167YReal-time PCRUS pet Dog populationβ-tubulin isotype-1

Identifiers

PMID36958067
PMCPMC10068012
OpenAlexW4324144292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.